Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1467 of 1467 entries
View as:

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00607087 Org: User:
Start: 01/31/08 End: 06/30/09 Due: 06/30/10

Objective Study in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00451971 Org: User:
Start: 03/31/02 End: - Due: -

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)

Phase: N/A Priority: Normal
NCT ID: NCT05002777 Org: User:
Start: 12/07/21 End: 12/31/29 Due: 12/31/30

GEMOX: Oxaliplatin in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00261092 Org: User:
Start: 10/31/05 End: - Due: -

Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00964574 Org: User:
Start: 07/31/09 End: 07/31/10 Due: 07/31/11

Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00464256 Org: User:
Start: 04/30/04 End: 11/30/04 Due: 11/30/05

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

Phase: N/A Priority: Normal
NCT ID: NCT02414854 Org: User:
Start: 04/27/15 End: 11/23/17 Due: 11/23/18

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT03510715 Org: User:
Start: 08/31/18 End: 02/17/20 Due: 02/17/21

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT05128773 Org: User:
Start: 02/17/22 End: 10/13/22 Due: 10/13/23

Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants

Phase: N/A Priority: Normal
NCT ID: NCT00303316 Org: User:
Start: 02/28/06 End: 09/30/07 Due: 09/30/08

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT01900431 Org: User:
Start: 10/31/13 End: 04/30/16 Due: 04/30/17

Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03462069 Org: User:
Start: 03/12/18 End: 04/18/19 Due: 04/18/20

ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00272064 Org: User:
Start: 10/31/05 End: 05/31/08 Due: 05/31/09

Sarilumab Effect on the Pharmacokinetics of Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02017639 Org: User:
Start: 01/31/14 End: 03/31/16 Due: 03/31/17

Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00851084 Org: User:
Start: 02/28/09 End: 01/31/12 Due: 01/31/13

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR

Phase: N/A Priority: Normal
NCT ID: NCT00663390 Org: User:
Start: 12/31/07 End: - Due: -

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Compatibility - Stay on Frutal

Phase: N/A Priority: Normal
NCT ID: NCT00933907 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10